I'll call the meeting to order.
Welcome to meeting number 77 of the Standing Committee on Health and our study on antimicrobial resistance.
I have a couple of little things.
I understand our sound system is not working yet on our teleconference, but hopefully we'll get that fixed shortly.
I'm leaving a bit early, and the vice-chair is going to take over.
At the very end, we're going to have a look at the letter we wrote about Bill C-45 to see if everybody approves of the letter.
I'll introduce our guests, and we'll get into our discussion.
From Halton Healthcare, we have Dr. Neil Rau. He is an infectious diseases specialist and medical microbiologist. Welcome very much.
From the Canadian Patient Safety Institute, we have Sandi Kossey, senior director of strategic partnerships and priorities. Welcome.
Also from the Canadian Patient Safety Institute, we have Kim Neudorf, patient advocate with Patients for Patient Safety Canada. I understand you two are going to share your opening statement.
As an individual, by teleconference we have Dr. Yvonne Shevchuk, associate dean for academics and professor at the College of Pharmacy and Nutrition, University of Saskatchewan.
We'll open with 10-minute opening remarks, starting with Dr. Rau.
Dr. Rau, would you like to fill us in?